Number of HLFs | ||||||
---|---|---|---|---|---|---|
0 | 1 | 2 | ≥ 3 | P trend | P for interaction | |
Combined macrovascular and microvascular events | ||||||
Region of residence | 0.329 | |||||
Asia | 1.00 | 0.90 (0.71–1.14) | 0.76 (0.60–0.97) | 0.75 (0.55–1.02) | 0.007 | |
Not Asia | 1.00 | 0.81 (0.68–0.95) | 0.69 (0.58–0.82) | 0.65 (0.52–0.81) | < 0.001 | |
Sex | 0.301 | |||||
Men | 1.00 | 0.84 (0.72–0.98) | 0.69 (0.58–0.81) | 0.67 (0.54–0.84) | < 0.001 | |
Women | 1.00 | 0.88 (0.67–1.14) | 0.79 (0.60–1.03) | 0.72 (0.51–1.00) | 0.017 | |
Age, years | 0.511 | |||||
< 65 | 1.00 | 0.90 (0.72–1.13) | 0.71 (0.57–0.90) | 0.79 (0.59–1.06) | 0.004 | |
≥ 65 | 1.00 | 0.81 (0.68–0.96) | 0.72 (0.60–0.86) | 0.62 (0.49–0.78) | < 0.001 | |
Diabetes duration, years | 0.828 | |||||
< 7 | 1.00 | 0.73 (0.59–0.90) | 0.66 (0.53–0.81) | 0.63(0.48–0.84) | < 0.001 | |
≥ 7 | 1.00 | 0.92 (0.77–1.10) | 0.75 (0.62–0.90) | 0.71 (0.56–0.90) | < 0.001 | |
History of macrovascular disease | 0.206 | |||||
No | 1.00 | 0.88 (0.73–1.06) | 0.79 (0.65–0.96) | 0.72 (0.57–0.91) | 0.001 | |
Yes | 1.00 | 0.82 (0.67–1.00) | 0.64 (0.52–0.79) | 0.66 (0.49–0.88) | < 0.001 | |
History of microvascular disease | 0.919 | |||||
No | 1.00 | 0.82 (0.70–0.95) | 0.72 (0.62–0.84) | 0.64 (0.53–0.79) | < 0.001 | |
Yes | 1.00 | 0.93 (0.69–1.26) | 0.70 (0.51–0.95) | 0.82 (0.54–1.24) | 0.022 |